ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 129 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $398,000 | +41.6% | 21,139 | -12.1% | 0.00% | – |
| Q2 2019 | $281,000 | +6.0% | 24,062 | +23.5% | 0.00% | – |
| Q1 2019 | $265,000 | -90.4% | 19,476 | -92.8% | 0.00% | -100.0% |
| Q4 2018 | $2,761,000 | -69.5% | 269,509 | -50.4% | 0.00% | -33.3% |
| Q3 2018 | $9,045,000 | -27.0% | 543,366 | -30.7% | 0.00% | -25.0% |
| Q2 2018 | $12,388,000 | +87.2% | 784,149 | +50.4% | 0.00% | +33.3% |
| Q1 2018 | $6,619,000 | +89.6% | 521,308 | +70.9% | 0.00% | +50.0% |
| Q4 2017 | $3,491,000 | +17.2% | 304,972 | +25.3% | 0.00% | 0.0% |
| Q3 2017 | $2,979,000 | +56.4% | 243,361 | +46.1% | 0.00% | +100.0% |
| Q2 2017 | $1,905,000 | -24.7% | 166,583 | +36.8% | 0.00% | -50.0% |
| Q1 2017 | $2,530,000 | -23.2% | 121,770 | -23.2% | 0.00% | -33.3% |
| Q4 2016 | $3,294,000 | -45.3% | 158,530 | -13.8% | 0.00% | -25.0% |
| Q3 2016 | $6,022,000 | +35.0% | 183,825 | +2.9% | 0.00% | +33.3% |
| Q2 2016 | $4,460,000 | -41.1% | 178,713 | -42.2% | 0.00% | -50.0% |
| Q1 2016 | $7,569,000 | +452.9% | 309,165 | +644.9% | 0.01% | +500.0% |
| Q4 2015 | $1,369,000 | -39.8% | 41,506 | -40.2% | 0.00% | -50.0% |
| Q3 2015 | $2,273,000 | -51.7% | 69,455 | -21.9% | 0.00% | -33.3% |
| Q2 2015 | $4,708,000 | +788.3% | 88,953 | +382.5% | 0.00% | – |
| Q1 2015 | $530,000 | – | 18,437 | +54126.5% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 34 | -99.7% | 0.00% | – |
| Q3 2014 | $128,000 | -20.5% | 10,244 | +26.8% | 0.00% | – |
| Q2 2014 | $161,000 | – | 8,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |